Article Details
Retrieved on: 2018-07-26 05:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Healx, a Cambridge, UK-based developer of treatments for rare diseases, secured $10m in Series A funding. The round was led by <b>Balderton Capital</b> ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here